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dummy variables or as linear terms. Additional terms were explored to account 
for interactions between domains. Among the candidate models, a random effects 
model with main effects presented as linear terms, terms for level 3 or higher 
in usual activities, pain/discomfort (PD), and anxiety/depression (AD), a term for 
whether dimension was at level 4 or level 5, and the interaction term between PD 
and AD performed better than the other models. ConClusions: This model can 
be used to estimate a Canadian TTO-based EQ-5D-5L value set.
PIH53
DeveloPIng A generIc DescrIPtIve system For cHIlDren’s HeAltH: A 
QuAlItAtIve stuDy
Kang E., Han G.R., Kim H.J.
Soonchunhyang University, Asan City, South Korea
objeCtives: Although there are several general valuation tools for health states 
have been developed for adults, there are few of those for children. In addition, it 
is arguable that the health dimensions included in the health descriptive system 
developed in the Western countries are valid in the Eastern countries like Korea. The 
purpose of this study was to elicit health dimensions of children as the first step 
of developing a general valuation tool for children’s health states. Methods: The 
sample was recruited from one elementary school in Cheonan city, Korea. The total 
number of participants was 40: 22 boys and 18 girls, 15 from grade 1 through 3 and 
25 from grade 4 through 6. Interviews were done in a group of 3 to 4 children of the 
same grade. Two trained interviewers asked various open-ended questions includ-
ing “What comes up in your mind when you hear the word ‘health’ and why do you 
think so?” All the interviews were recorded and transcribed. NVivo 10 was used for 
the qualitative analysis. Currently, more samples are recruited from outpatients to 
a university hospital, which will be added to the analysis by the time of the confer-
ence. Results: Over 100 words and phrases that were directly or indirectly related 
to concept of health were extracted. After carefully and repeatedly reviewing these 
words and phrases, we categorized them into similar meaning units. As a result, we 
could obtain 13 themes including food/nutrition, physical activity, usual activities, 
loneliness, depression/anxiety, pain, good mood/joyfulness, robustness/good stat-
ure, playing with friends, family, fear, longevity, disease/treatment. ConClusions: 
The study found new dimensions that had not been included in the previous health 
descriptive systems for children such as food/nutrition, robustness/good stature, 
and family. This implies that children from different cultural backgrounds might 
need different general health descriptive systems.
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tIme trADe-oFF utIlIty Assessment wItH A 10-yeAr tIme HorIzon: 
wHen sHoulD AlternAtIve APProAcHes be consIDereD?
Boye K.S.1, Matza L.S.2, Feeny D.H.3, Johnston J.A.1, Bowman L.1, Jordan J.2
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objeCtives: In recent years, the time trade-off (TTO) method with a 10-year time 
horizon has been the most frequently used approach for direct health-state util-
ity assessment. It is likely that researchers have favored this method because the 
National Institute of Health and Clinical Excellence (NICE) Guide to the Methods 
of Technology Appraisal states a preference for consistency with the EQ-5D, which 
has a utility scoring algorithm derived using 10-year TTO valuations. Although com-
parability to previous utility studies is important, there are situations when the 
10-year TTO is not optimal. Methods: A review of the literature was conducted 
to identify situations when TTO with a 10-year time horizon may not be the most 
appropriate method for eliciting health-state utilities. Results: Five challenges to 
the 10-year TTO method include mild health states, small differences among health 
states, temporary health states, pediatric health states, and assessment of samples 
with particular characteristics. In these situations, the 10-year TTO may not yield 
valid utility scores, detect small but important differences among health states, or 
accurately represent the clinical condition being studied. Alternative approaches 
are suggested, including variations of the TTO (e.g., varying the time horizon), other 
direct utility assessment methods (e.g., standard gamble with or without chaining), 
measures developed specifically for children, mapping condition-specific health-
related quality of life questionnaires to generic preference measures, and condi-
tion-specific preference-based measures derived from longer condition-specific 
questionnaires using Rasch and item-response theory methods. ConClusions: 
Rather than simply using the most commonly used method, it is recommended that 
investigators select a utility assessment method based on its relevance and validity 
for particular clinical contexts and health states. Pilot studies are often helpful in 
identifying the optimal approach.
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Do utIlIty vAlues reFlect lost Income AnD tHe Full oPPortunIty 
cost oF work loss?
Fust K.1, Kohli M.2, Ball G.2, Kawai K.3, Acosta C.J.3, Weinstein M.C.4
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PA, USA, 4Harvard School of Public Health, Boston, MA, USA
objeCtives: The US Panel on Cost-Effectiveness recommends excluding productiv-
ity losses from numerators of cost-effectiveness ratios. This critical literature review 
evaluated evidence as to whether individuals consider work loss when completing 
utility assessments reflected in the denominator. Methods: PubMed/MEDLINE, 
Cochrane, and EMBASE databases were searched using terms such as “quality of 
life”, “productivity”, “utility”, and “EQ-5D”. Titles/abstracts of 1,114 identified stud-
ies were double screened using pre-defined criteria. References from key articles 
were manually reviewed. Sixteen relevant publications were identified. Results: 
Nine studies representing 6 countries (Australia (1), Japan (1), The Netherlands (4), 
Sweden (1), Switzerland (1), United States (1)) asked respondents if they sponta-
neously considered income effects or believed study health states would impact 
income. Between 31% and 64% of respondents in 6 studies indicated they considered 
lost income effects in health state valuations in situations where they had been 
HIT interventions. Research evaluating the long term health and cost outcomes of 
improving medication adherence using HIT interventions is also recommended.
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PersIstence wItH testosterone rePlAcement tHerAPy
Camper S.B.1, Puenpatom R.A.1, Blanchette C.M.2, Ma L.1
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objeCtives: Very limited data exist on patient persistence with testosterone 
replacement therapy (TRT). Furthermore, no persistence data are available for the 
long-acting injection (LAI) formulation. Therefore, the objective of this analysis was 
to compare medication persistence and first switching patterns among patients 
initiating LAI with those using other testosterone formulations. Methods: This 
was a retrospective database analysis of 17,385 patients receiving TRT in Germany 
between 2008 and 2012 based on the IMS®Health German Longitudinal Prescriptions 
(LRx) database. The main outcome measure was the percentage of patients who 
were persistent with their index TRT at 24 months from initiation. Results: During 
the study period, patients receiving the LAI remained on their initial therapy sig-
nificantly longer than patients using capsules, gels or short-acting injections (SAIs) 
(p< 0.001). At three months, 70.1% of patients with the LAI were persistent with 
their initial TRT compared with 39.1% of patients receiving the gels and 14.7% 
of patients treated with the SAI. At 24 months, 20.2% of those receiving the LAI 
remained on their initial therapy vs. 9.7%, 5.7% and 0.5% for capsule, gels and SAIs, 
respectively. Sensitivity analyses showed consistent results. A total of 3,115 (17.9%) 
patients switched to a different product, with those starting on a LAI having the 
lowest switching rate (6.2%) and those starting with SAIs having the highest rate 
(24.2%). ConClusions: While persistence with TRT decreased substantially over 
time, treatment with the long-acting injection demonstrated higher persistence 
compared with the gels, capsule, and short-acting injections. Persistence with treat-
ment for low testosterone may be enhanced by the administration of testosterone 
utilizing a technology that prolongs the availability of drug and reduces dosing 
frequency.
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Dose escAlAtIon For InFusIon bIologIcs wItH FlexIble DosIng 
scHeDules
Kozma C.1, Paris A.2, Ingham M.3
1CK Consulting, Saint Helena Island, SC, USA, 2Vigilytics, Victor, NY, USA, 3Janssen Scientific 
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objeCtives: To describe the frequency of and time to dose escalation for incident 
infliximab(IFX) or tociluzumab(TCZ) patients. Methods: This retrospective, obser-
vational analysis used national data from Symphony Health Solutions (SHS). All 
claims for adult IFX or TCZ (index biologic) patients were extracted from January 1, 
2009 to December 31, 2011. Proxy eligibility criteria ensured complete claims and 
excluded pre-index biologic users. IFX and TCZ patients were excluded if their calcu-
lated daily dose was < 200mg or > 1200mg (IFX) and < 200mg or > 800mg (TCZ) or if the 
times between infusions were < 14 days or < 25 days respectively, or if patients had 
biologic claims in both the prescription and procedure (Px) files. Within the first 180 
days post index, patients with ≥ 3 Px claims were classified by their dose change over 
the first 3 dosages, reporting any dose increase, dose doubling at any time, the time 
to dose doubling and the time between claims (infusions). Results are descriptive, 
and cohorts were not adjusted for differences. Results: 25,451 IFX patients (11,948 
RA) and 1593 TCZ patients (1584 RA) contributed data. For overall sample, patients 
with ≥ 3 Px claims (n= 20,131 IFX; n= 1285 TCZ), mean initial doses were 410mg (IFX) 
and 456mg (TCZ). By dose 2, 6.9% of IFX and 22.2% of TCZ patients experienced a 
dose increase. By dose 3, 81.8% of IFX patients and 55.0% of TCZ patients remained 
on the same dose relative to their initial dose. Within 180 days, 4.9% of IFX and 18.0% 
of TCZ patients doubled their initial dose. Median time to dose doubling was 99 days 
(IFX) and 58 days (TCZ). ConClusions: Dose escalation appears to happen more 
frequently and more quickly after patients initiate TCZ than when initiating IFX. 
The excess dose doubling with TCZ may have important economic implications.
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objeCtives: The EQ-5D-5L has the same five domains as in the EQ-5D but with 
5 response options reflecting no, mild, moderate, severe, and extreme problems 
in each domain. The primary objective of this study was to develop a value set of 
the EQ-5D-5L in Canada. Methods: The combination of traditional and lead-time 
time trade-off (TTO) was one of the main valuation techniques. A total of 80 health 
states plus the 5 very mild states (with only one dimension at level 2) randomly 
grouped into 10 blocks were evaluated using the TTO. State “55555”was included in 
every block. Each participant was asked to complete one block of 10 states through 
a face-to-face interview. Quota sampling was used to select a representative sam-
ple from the Canadian general population in terms of gender, age, and education. 
Interviews were conducted in Vancouver, Edmonton, Montreal and Hamilton 
between November 2012 and September 2013. Various functional forms and model 
estimators were used to estimate a TTO-based value set. Results: A total of 1209 
participants completed the interview with the mean age of 47.6 years and 54.8% 
being female. Candidate models were compared using face validity (severer states 
have lower values), mean absolute error (MAE), mean squared error (MSE), and 
Akaike Information Criterion (AIC). The main effects were presented using either 
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(engagement or measurement) and the focus of the article (health care, research, 
or teaching). Results: Our search identified 5051 publications from 1966-2013. We 
found a steep increase in the term’s use in recent decades. In the 1960s, ‘70s, and 
‘80s, < 50 articles were identified per decade. The number increased to > 350 in the 
90s, > 1550 in the 2000s and > 3000 in the 2010s. The vast majority (> 80%) of publica-
tions from the 1960s-2009 focused on patient engagement. However, from 2010-2013, 
the focus was equally split between engagement and measurement of PROs. From 
1966-2013, articles reporting original research increased from 17% to 90%. In early 
decades, qualitative research proliferated, whereas research since 2010 employed 
more quantitative epidemiological methods. There was also a notable shift from a 
single-disciplinary approach in the early decades to a multidisciplinary approach in 
the later decades. ConClusions: Since its introduction in scientific literature, the 
term patient-centered has flourished, with tremendous increases noted in the last 
decade. The concept has evolved from purely patient engagement to encompass both 
engagement and measurement of PROs and from qualitative to more rigorous scien-
tific methods. These findings are congruent with the current personalized-medicine 
approach that characterizes the health care industry today.
PIH59
An AnAlysIs oF HcAHPs scorIng AnD tHe ImPAct oF tHe PAIn 
mAnAgement DImensIon on HosPItAl PerFormAnce
Abraham J.1, Jones J.2, Baker G.1, Arpino P.1
1The Medicines Company, Waltham, MA, USA, 2The Medicines Company, Parsippany, NJ, USA
objeCtives: The Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey captures patient satisfaction across 8 dimensions. CMS 
compares a facility’s most positive rating in each dimension (“top-box”) against 
three scores calculated from the national sample during a baseline period. Pain 
management is the only HCAHPS dimension directly related to a patient’s medical 
condition while concurrently influencing overall patient experience and satisfac-
tion. This study utilizes CMS data and HCAPHS survey results to evaluate current 
HCAHPS pain measures across facilities, and the potential benefit to overall HCAHPS 
scores by improving pain management in an inpatient setting. Methods: Baseline 
scores (low, middle, and high) from FY2013 through FY2016 were collected and 
evaluated for trends and impact on performance scores. A set of hospitals was 
selected based on participation in CMS data collection and HCAHPS survey admin-
istration. The average hospital domain scores were tabulated for all 8 dimensions 
for FY2013 and FY2014. A direct comparison was made between the changes in pain 
management dimension and all other dimensions. Results: Between FY2013 and 
FY2014 the pain management middle and high baseline scores will increase by 0.3% 
and 0.03% while the other 7 dimensions will increase on average, 1.0% and 0.4% 
respectively. Mean “top-box “ratings between FY2013-2014 changed by less than 
1% across all dimensions. The disparity in baseline scores over the same period 
led to a change in pain dimension scores by 3%, while the other 7 dimensions saw 
performance scores change in the range of 2% - > 10%. ConClusions: This analysis 
illustrates that changes to the baseline scores may have a significant impact on 
HCAHPS performance scores. As a result, proportional improvement in pain scores 
will disproportionately increase overall HCAHPS scores compared with the other 
7 dimensions, indicating an increased importance of adequate pain management 
on overall patient satisfaction and Medicare payment.
PIH60
IncluDIng PAtIents’ PreFerences In tHe DecIsIon mAkIng Process to 
DetermIne tHe content oF HeAltH beneFIt PlAns: A nArrAtIve revIew
Moreno-Mattar O., Mejia A.
Instituto De Evaluación Tecnológica En Salud - Iets, Bogota, Colombia
objeCtives: Identify the main methodologies used to include patients’ prefer-
ences in the decision making process to determine the content of health benefit 
plans. Methods: We systematically searched electronic databases (MEDLINE, 
EMBASE, The Campbell Collaboration, JStor, Health System Evidence, DoPHER and 
LILACS) for studies that were published from the inception of the databases to 
September 16 2013. We excluded editorials, letters to the editor, communications, 
abstracts and any article related to preferences for particular technologies or stud-
ies describing decisions about specific diseases. Results: We found 1.868 non-
duplicate citations in the electronic search; 33 were assessed for eligibility and 
finally, 12 studies were included in the analysis (3 reviews and 9 individual studies). 
The reviews concluded that it is important to use simple, objective and inclusive 
methods to include patients’ preferences in decision making processes but don’t 
recommend any specific methodology. The other studies used methodologies favor-
ing public engagement and public participation, citizens’ jury, conjoint analysis, 
discrete choice experiment method and CHAT (Choosing Healthplans All Together). 
These studies were mainly conducted in High Income Countries (United States, 
Germany, Canada, UK and Hungary). CHAT was the methodology most commonly 
used because it is an exercise that patients understand easily, and researchers 
recognize as practical and objective. ConClusions: There is a growing interest 
in public engagement in priority setting in health. The methods and characteris-
tics of the studies evaluating methodologies used to include patients’ preferences 
in the decision making process to determine the content of health benefit plans 
varied, and it is difficult to make comparisons. Some methodologies such as con-
joint analysis methods might need more time to develop. Researchers believe it is 
important that the methodologies are easy for patients to understand to facilitate 
their participation.
PIH61
tHe role oF socIo-economIc FActors In DetermInIng contrAcePtIve 
cHoIce In InDonesIA
Meng R., Polimeni J.
Albany College of Pharmacy and Health Sciences, Albany, NY, USA
objeCtives: The study determines socio-economic factors that influence the likeli-
hood of a married woman in Indonesia on contraceptive choice. Methods: The 
given no instruction whether to consider income. Two studies reported significantly 
lower proportions (Sweden: 4%; United States: 15%), while 1 study a higher propor-
tion (Japan: 77%). Differences in study population (students versus general), health 
state severity, and utility elicitation method (time trade off versus visual analogue 
scale) may explain conflicting results. The impact of cultural attitudes towards work 
and the social security net (e.g. wage replacement rates) is not clear. No published 
studies shed light on whether respondents consider income loss when assigning 
utilities to the EQ-5D or other widely-used generic health tariffs. ConClusions: 
In many studies reviewed, a large proportion of respondents stated that they did 
not consider income loss during utility elicitation, suggesting income loss is not 
fully captured in health state valuations. Further research is needed to determine 
whether productivity losses are fully captured in QoL measurements for health 
scales such as the EQ-5D, or if the economic value of work loss should be included 
explicitly in cost-effectiveness analyses.
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swItcHIng Drugs: economIc AnD clInIcAl outcomes
Al Ameri M.
Zayed Military Hospital Camp, Abu Dhabi, United Arab Emirates
objeCtives: This paper explores some ethical issues that may arise in the con-
text of generic and therapeutic substitution by evaluating patients’ awareness and 
understanding of drug substitution. Methods: A literature review and a survey 
of a total of 163 patients using a questionnaire containing 36 questions. Results: 
Majority of patients had a kidney transplant for more than a year ago and were 
highly educated. Overall key findings concluded that 84% of patients were aware 
of the availability of generic medicines, 70% understood the term “generic” and 
“branded” in relation to medicines and 54% were aware of generic substitution 
practice. However, 75% did not know if they were taking generic medicines and 84% 
felt that generics were not equivalent or only equivalent sometimes, and they were 
uncertain that generics had the same quality as branded medicines. Of patients on 
generics, 66% were dissatisfied or uncertain about their satisfaction concerning 
generic medicines and 55% experienced noticeable differences between the branded 
and generic medicines mostly in the packaging, shape, colour or taste and felt that 
the branded medicines are more effective than their counterpart generics. Of these, 
75% admitted that adapting to these differences was problematic. This practice has 
been considered ethical on the basis of the presumption that the cheaper drug is 
not inferior to the more expensive one and the premise that any saving that does 
not compromise the quality of care is ethical. Indeed, under such circumstances 
substitution raises no ethical problem whatsoever. ConClusions: Many patients 
are distrustful of generics because they consider these drugs as being less expensive, 
less effective and associated with increased adverse events. The lack of transparency 
around generic substitution is of concern and might lead to confusion or worry on 
the patients’ side. Promoting generic and therapeutic substitution on economic 
grounds alone is potentially dangerous and unethical.
PIH57
AttrActIveness oF Pro mIxeD moDes – wHAt Are PAtIents sAyIng?
Ross J., Holzbaur E.
Almac Clinical Technologies, Souderton, PA, USA
objeCtives: An important industry topic is the utilization of mixed PRO modes 
in clinical trials. Using mixed modes may be beneficial for sponsors, but there is a 
lack of evidence supporting that data from different modes renders equivalence 
across modes. Given the industry’s interest in mixed modes, a qualitative research 
investigation was done to see if patients would be accepting if mixed modes were 
introduced into clinical trials. Methods: A global internet-based survey was 
administered to patients who participated in at least 1 trial including patient diaries 
in the past 2 years. The survey included a qualitative section that asked patients 
to explain how attractive the option to utilize several different modes of patient 
diaries would be versus one mode alone in future trials. Responses were examined 
and placed into categories for analysis. Results: 346 patients provided analyzable 
responses. 67.1% indicated they favored multiple modes, 29.5% were against; 2.9% 
neutral, and 0.6% undecided. For those favoring mixed modes, 41.4% indicated that 
they liked options/choices, 19.4% indicated that it would be easier/more convenient, 
13.4% indicated being attracted to choosing their preferred mode, 12.9% indicated 
that it would allow for better access, and 12.9% found the flexibility to be attractive. 
For those who were against, 31.4% indicated that they preferred using one mode, 
28.4% were interested only in using their preferred mode, 20.6% indicated it would 
be confusing, and 19.6% indicated it would be more complicated. ConClusions: 
Results show that many patients would be accepting of mixed modes, but the 
acceptance is not unanimous. Mixed modes may be a part of future clinical studies 
if equivalence evidence is established. By examining responses of those against 
mixed modes, patients’ concerns can be identified and addressed. Common mes-
sages identified include keeping the modes easy to use and selecting proper choice 
of modes for administration.
PIH58
evolutIon oF tHe PAtIent-centereD concePt In tHe PublIsHeD 
lIterAture
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objeCtives: In today’s health care arena, the term “patient-centered” is typically used 
to describe either: 1) the engagement of patients in managing their health or 2) the 
measurement of patient-reported outcomes (PROs). The objective of this study was 
to explore the evolution of the patient-centered concept as reported in the scientific 
literature. Methods: We searched EMBASE for articles written in English between 
1950-2013 with ‘patient-centered’ in the title or abstract. We examined trends in the 
concept’s use over time by graphing the number of publications by year. We selected 
a random sample of 10 articles within each decade and captured data on the context 
